Clinical Trial Update: Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy of intravenous immunoglobulin in patients with hemorrhagic fever with renal syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Fever with Renal Syndrome

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Tongji Hospital | Conditions: HFRS (Hemorrhagic Fever With Renal Syndrome) | Phase 4 | Status: UNKNOWN